menu
    • menu

    Company profile for Cartography Biosciences

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cartography Biosciences specializes in platform-based cell therapy, utilizing single-cell analysis to identify innovative CAR-T (Chimeric Antigen Receptor T-cell) targets. Their approach integrates molecular biology and computational methods to advance the study and development of cancer immunotherapies. By leveraging their technology, Cartography Biosciences enables clients to pinpoint precise targets for CAR-T cell therapies...
    Cartography Biosciences specializes in platform-based cell therapy, utilizing single-cell analysis to identify innovative CAR-T (Chimeric Antigen Receptor T-cell) targets. Their approach integrates molecular biology and computational methods to advance the study and development of cancer immunotherapies. By leveraging their technology, Cartography Biosciences enables clients to pinpoint precise targets for CAR-T cell therapies, enhancing the effectiveness and specificity of treatments aimed at combating cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cartography BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    230 E Grand Avenue, Suite 250 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cartography.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cartographybio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cartography Biosciences Launches CBI-1214 Phase 1 Trial
    Cartography Biosciences Launches CBI-1214 Phase 1 Trial

    24 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-24/cartography-biosciences-doses-first-patient-in-phase-1-trial-of-cbi-1214-a-highly-specific-t-cell-e

    PHARMIWEB
    24 Feb 2026
    Share Share
    Cartography, Pfizer Partner on Tumor-Selective Therapies
    Cartography, Pfizer Partner on Tumor-Selective Therapies

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106591786/en/Cartography-Biosciences-and-Pfizer-to-Collaborate-on-the-Discovery-of-Tumor-Selective-Antigens

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Cartography Gets FDA (IND) Approval & Fast Track For CBI-1214
    Cartography Gets FDA (IND) Approval & Fast Track For CBI-1214

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/cartography-receives-fda-investigational-new-drug-ind-approval-and-fast-track-designation-for-lead

    PHARMIWEB
    18 Dec 2025
    Share Share
    Cartography Extends Sequencing Boundaries To Detect Bananas Amid
    Cartography Extends Sequencing Boundaries To Detect Bananas Amid

    15 Oct 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/cartography-pushes-sequencing-to-the-limit-to-find-bananas-in-100-apples

    BIOSPACE
    15 Oct 2025
    Share Share
    Cartography Raises $67M Series B to Advance Oncology Antibody
    Cartography Raises $67M Series B to Advance Oncology Antibody

    02 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251002482177/en/Cartography-Secures-%2467-Million-Series-B-Financing-to-Advance-Differentiated-Oncology-Pipeline-of-Antibody-Based-Therapies-into-the-Clinic

    BUSINESSWIRE
    02 Oct 2025
    Share Share
    Cartography Names Dirk as CMO in Expansion of Clinical Team
    Cartography Names Dirk as CMO in Expansion of Clinical Team

    03 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250903830459/en/Cartography-Names-Dirk-Nagorsen-M.D.-as-Chief-Medical-Officer-in-Expansion-of-Its-Clinical-Team

    BUSINESSWIRE
    03 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search